Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-10-04
2005-10-04
Moran, Marjorie (Department: 1631)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S206100, C424S201100
Reexamination Certificate
active
06951649
ABSTRACT:
The present invention relates to a method for formulating a vaccine composition which comprises an anti-influenza vaccine, wherein the improvement of the vaccine composition is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The improved composition can include and be administered with an adjuvant. The improved vaccine composition provides protection in a host, animal or human, against influenza infection, including viral replication and systemic infection.
REFERENCES:
patent: 4247539 (1981-01-01), Iritani et al.
patent: 4631191 (1986-12-01), Dale et al.
patent: 4693893 (1987-09-01), Campbell
patent: 5728385 (1998-03-01), Classen
patent: 5962298 (1999-10-01), Fiers
patent: 5976552 (1999-11-01), Volvovitz
patent: 6485729 (2002-11-01), Smith et al.
Webster et al. Potentation of the Immune Response to Influenza Virus Subunit Vaccines J. Immunology (1997) vol. 199 (6) pp. 2073-2077.
Kuroda et al. Expression of the Influenza Virus Haemagglutinin in Insect Cells by a Baculovirus Vector EMBO Journal vol. No. 6 pp. 1359-1365, 1986.
Connaught Laboratories Inc. Rabies Immune Globulin 90B Physicians Desk Reference, 1995 (Medical Economics Data Production Company, Montvale, NJ).
Mather et al. Expression of Influenza Neuraminidase in Baculovirus-Infected Cells, Virus Research, 26(2): 127-139, 1992.
Hausmann, et al. “N1 neuraminidase of influenza virus A/FPV/Rostock/34 has haemadsorbing activity,” Journal of General Virology 76: 1719-1728, 1995 abstract only.
Johansson, et al. “Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants,” Vaccine, vol. 13, No. 9. pp. 841-845, 1995.
Deroo, et al. “Recombinant neuraminidase vaccine protects against lethal influenza,” Vaccine, vol. 14, No. 6, pp. 561-569, 1996.
Yue-xin, et al. “Expression of Neurominidase of Influenza Virus in Insect Cells,” Chinese Journal of Biochemistry and Biophysics, vol. 25, No.4, pp. 237-241, 1992 (reprinted 1993 in Englsh).
Hackett Craig S.
Johansson Bert E.
Kilbourne Edwin D
Matthews James T.
Smith Gail Eugene
Collison Angela M.
Frommer & Lawrence & Haug LLP
Kowalski Thomas J.
Moran Marjorie
Protein Sciences Corporation
LandOfFree
Methods of making neuraminidase-supplemented compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of making neuraminidase-supplemented compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of making neuraminidase-supplemented compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3451462